{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:26:50Z","timestamp":1794324410390,"version":"4.9.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.humimm.2026.112086","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:33:42Z","timestamp":1790696022000},"page":"112086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rational truncation of streptokinase reduces immunogenicity while preserving plasminogen activation: In vitro and in vivo analysis"],"prefix":"10.1016","volume":"87","author":[{"given":"Vijay","family":"Gunasekaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pichaimuthu","family":"Suthakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vigneshwaran","family":"Namasivayam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Ponnusami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.humimm.2026.112086_bb0005","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/ATVBAHA.124.320151","article-title":"Global health burden of venous thromboembolism","volume":"44","author":"Wendelboe","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.humimm.2026.112086_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2020.108651","article-title":"Interrelations between COVID-19 and other disorders","volume":"224","author":"Gasmi","year":"2021","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2026.112086_bb0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/1574890110999150202150017","article-title":"Streptokinase-A drug for thrombolytic therapy: a patent review","volume":"9","author":"Kunamneni","year":"2014","journal-title":"Recent Pat. Cardiovasc. Drug Discov."},{"key":"10.1016\/j.humimm.2026.112086_bb0020","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/jth.12629","article-title":"Biosimilars: the process is the product. The example of biosimilar streptokinase","volume":"12","author":"Thelwell","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.humimm.2026.112086_bb0025","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4161\/self.1.4.13904","article-title":"Immunogenicity of protein therapeutics: the key causes, consequences and challenges","volume":"1","author":"Baker","year":"2010","journal-title":"Self\/Non Self"},{"key":"10.1016\/j.humimm.2026.112086_bb0030","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.clim.2013.09.006","article-title":"T-cell dependent immunogenicity of protein therapeutics: preclinical assessment and mitigation","volume":"149","author":"Jawa","year":"2013","journal-title":"Clin. Immunol."},{"issue":"10","key":"10.1016\/j.humimm.2026.112086_bb0035","first-page":"541","article-title":"Streptokinase immunogenicity in thrombolytic therapy for acute myocardial infarction","volume":"27","author":"Rosenschein","year":"1991","journal-title":"Isr. J. Med. Sci."},{"issue":"8","key":"10.1016\/j.humimm.2026.112086_bb0040","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/0002-9149(93)91003-Z","article-title":"Neutralizing antibodies to streptokinase four years after intravenous thrombolytic therapy","volume":"71","author":"Elliott","year":"1993","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.humimm.2026.112086_bb0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/qjmed\/hcg020","article-title":"Superiority and equivalence in thrombolytic drugs: an interpretation","volume":"96","author":"Walley","year":"2003","journal-title":"QJM"},{"key":"10.1016\/j.humimm.2026.112086_bb0050","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1053\/euhj.1999.1528","article-title":"Humoral and cellular immune responses up to 7\u00b75 years after administration of streptokinase for acute myocardial infarction","volume":"20","author":"Squire","year":"1999","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.humimm.2026.112086_bb0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/138945009787354511","article-title":"Reducing the immunogenicity of protein therapeutics","volume":"10","author":"Onda","year":"2009","journal-title":"Curr. Drug Targets"},{"issue":"5","key":"10.1016\/j.humimm.2026.112086_bb0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00063030-200822050-00004","article-title":"The impact of pegylation on biological therapies","volume":"22","author":"Veronese","year":"2008","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.humimm.2026.112086_bb0065","first-page":"17","article-title":"Review on streptokinase with its antigenic determinants and perspectives to develop its recombinant enzyme with minimum immunogenecity","volume":"6","author":"Akbar","year":"2020","journal-title":"J. Innovat. Sci."},{"key":"10.1016\/j.humimm.2026.112086_bb0070","first-page":"38","article-title":"A review on successive generations of streptokinase based thrombolytic agents","volume":"4","author":"Mrinmoy","year":"2012","journal-title":"Int. J. Pharm. Pharm. Sci."},{"issue":"49","key":"10.1016\/j.humimm.2026.112086_bb0075","doi-asserted-by":"crossref","first-page":"29601","DOI":"10.1074\/jbc.270.49.29601","article-title":"Interaction of Streptokinase and Plasminogen","volume":"270","author":"Young","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2026.112086_bb0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jbiotec.2026.01.004","article-title":"Integrative experimental and computational approach for the development of novel plasminogen activators from truncated streptokinase fragments","volume":"411","author":"Gunasekaran","year":"2026","journal-title":"J. Biotechnol."},{"issue":"4","key":"10.1016\/j.humimm.2026.112086_bb0085","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/pro.5560050414","article-title":"The domain organization of streptokinase: nuclear magnetic resonance, circular dichroism, and functional characterization of proteolytic fragments","volume":"5","author":"Parrado","year":"1996","journal-title":"Protein Sci."},{"issue":"12","key":"10.1016\/j.humimm.2026.112086_bb0090","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1002\/pro.5560051221","article-title":"Thermal stability of the three domains of streptokinase studied by circular dichroism and nuclear magnetic resonance","volume":"5","author":"Conejero-Lara","year":"1996","journal-title":"Protein Sci."},{"issue":"9","key":"10.1016\/j.humimm.2026.112086_bb0095","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0161-5890(92)90042-V","article-title":"At least five antigenic epitopes on the Streptokinase molecule are recognised by human CD4+ TCR\u03b1\u03b2+ T CELLS","volume":"29","author":"Bruserud","year":"1992","journal-title":"Mol. Immunol."},{"issue":"10","key":"10.1016\/j.humimm.2026.112086_bb0100","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.4049\/jimmunol.150.10.4407","article-title":"A functional analysis of the antigenicity of streptokinase using monoclonal antibody mapping and recombinant streptokinase fragments","volume":"150","author":"Reed","year":"1993","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2026.112086_bb0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/hyb.1996.15.169","article-title":"Structural characterization of immunodominant regions of streptokinase recognized by murine monoclonal antibodies","volume":"15","author":"Parhami-Seren","year":"1996","journal-title":"Hybridoma"},{"key":"10.1016\/j.humimm.2026.112086_bb0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/jmbi.1997.1174","article-title":"Sequences of antigenic epitopes of streptokinase identified via random peptide libraries displayed on phage","volume":"271","author":"Parhami-Seren","year":"1997","journal-title":"J. Mol. Biol."},{"issue":"10","key":"10.1016\/j.humimm.2026.112086_bb0115","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0161-5890(95)00041-C","article-title":"Mapping the antigenic regions of streptokinase in humans before and after streptokinase therapy","volume":"32","author":"Parhami-Seren","year":"1995","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.humimm.2026.112086_bb0120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/bbrc.1999.0747","article-title":"Mapping of the antigenic regions of streptokinase in humans after streptokinase therapy","volume":"259","author":"Torrens","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.humimm.2026.112086_bb0125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1042\/cs0990239","article-title":"T-cell recognition of discrete regions of the thrombolytic drug streptokinase","volume":"99","author":"Lawley","year":"2000","journal-title":"Clin. Sci."},{"key":"10.1016\/j.humimm.2026.112086_bb0130","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1046\/j.0014-2956.2001.02472.x","article-title":"New antigenic regions of streptokinase are identified by affinity-directed mass spectrometry","volume":"268","author":"Coffey","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.humimm.2026.112086_bb0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0165-2478(99)00151-0","article-title":"A mutant streptokinase lacking the C-terminal 42 amino acids is less immunogenic","volume":"70","author":"Torrens","year":"1999","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.humimm.2026.112086_bb0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-1759(02)00435-0","article-title":"Structural correlates of a functional streptokinase antigenic epitope: serine 138 is an essential residue for antibody binding","volume":"272","author":"Parhami-Seren","year":"2003","journal-title":"J. Immunol. Methods"},{"issue":"3","key":"10.1016\/j.humimm.2026.112086_bb0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.33073\/pjm-2011-034","article-title":"A comparative study on the activity and antigenicity of truncated and full-length forms of streptokinase","volume":"60","author":"Arabi","year":"2011","journal-title":"Pol. J. Microbiol."},{"key":"10.1016\/j.humimm.2026.112086_bb0150","article-title":"Protenix - advancing structure prediction through a comprehensive AlphaFold3 reproduction","author":"Chen","year":"2025","journal-title":"bioRxiv"},{"issue":"12","key":"10.1016\/j.humimm.2026.112086_bb0155","doi-asserted-by":"crossref","first-page":"btaf606","DOI":"10.1093\/bioinformatics\/btaf606","article-title":"COCOMAPS 2.0: a web server for identifying, analyzing, and visualizing atomic interactions at the interface of biomolecular complexes","volume":"41","author":"Chawla","year":"2025","journal-title":"Bioinformatics"},{"key":"10.1016\/j.humimm.2026.112086_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0094-1","article-title":"The wide utility of rabbits as models of human diseases","volume":"50","author":"Esteves","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.humimm.2026.112086_bb0165","doi-asserted-by":"crossref","DOI":"10.1590\/1519-6984.271083","article-title":"Evaluation of clinical efficacy of streptokinase by comparison with the thrombolytic agent on animal model","volume":"84","author":"Yousaf","year":"2024","journal-title":"Braz. J. Biol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926004325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926004325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:52:21Z","timestamp":1794322341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885926004325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0198885926004325"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.112086","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational truncation of streptokinase reduces immunogenicity while preserving plasminogen activation: In vitro and in vivo analysis","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.112086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}],"article-number":"112086"}}